Identifying patients at risk for hereditary myeloid malignancy syndromes incorporating a novel, self-administered questionnaire to an initial screening platform.
Eur J Haematol
; 111(6): 844-850, 2023 Dec.
Article
in En
| MEDLINE
| ID: mdl-37587783
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Myeloproliferative Disorders
/
Neoplasms
Type of study:
Diagnostic_studies
/
Etiology_studies
/
Prognostic_studies
/
Risk_factors_studies
/
Screening_studies
Limits:
Humans
/
Middle aged
Language:
En
Year:
2023
Type:
Article